(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7

Pharmacogenetics

Volumn 5, Issue 1, 1995, Pages 43-49

  Patel, M ^a   Tang, B K ^a   Kalow, W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; CLOFIBRIC ACID; CODEINE; DRUG METABOLITE; ESTRIOL; FENOPROFEN; GLUCURONOSYLTRANSFERASE; HYODEOXYCHOLIC ACID; IBUPROFEN; ISOENZYME; KETOPROFEN; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZEPAM; OXAZEPAM GLUCURONIDE; PARACETAMOL; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIASTEREOISOMER; ENZYME KINETICS; GLUCURONIDATION; HUMAN; HUMAN TISSUE; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL; STEREOSPECIFICITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING, COMPETITIVE; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HUMAN; IN VITRO; ISOENZYMES; KETOPROFEN; KINETICS; MICROSOMES, LIVER; OXAZEPAM; STEREOISOMERISM; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0028837971     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199502000-00005     Document Type: Article

References (13)

1. Burchell B, Nebert DW, Nelson DR, Bock KW, Iyanagi T, Jansen PLM, Lancet D, Mulder GJ, Chowdhury JR, Siest G, Tephly TR, Mackenzie PI. The UDP glucuronosyltrans-ferase gene superfamily: Suggested nomenclature based on evolutionary divergence. DNA Cell Biol 1991: 10(7), 487-494.
2. Corbella A, Gariboldi P, Jommi G, Forgione A, Marcucci F, Martelli P, Mussini E, Mauri F. Stereochemistry of the enzymatic 3-hydroxy lation of l,3-dihydro-2H-l,4-benzodiazepin-2-ones. J. Chem Soc Chem Comm 1973: 721-722.
3. Dutton GJ. Glucuronidation of drugs and other compounds. Boca Raton, FL: CRC Press, 1980.
4. Greenblatt DJ, Divoll M, Abernathy DR, Ochs HR, Shader RI. Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1983: 8, 233-252.
5. Jin C, Miners JO, Lillywhite KJ, Mackenzie PI. Complementary deoxyribonucleic acid cloning and expression of human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 1993: 264(1), 475-479.
6. Mascher H, Nitsche V, Shutz H. Separation, isolation, and identification of optical isomers of 1,4-benzodiazepine glucuronides from biological fluids by reversed phase high-performance liquid chromatography. J Chromatogr Biomed Appl 1984: 306, 231-239.
7. Miners JO, Mackenzie PI. Drug glucuronidation in humans. Pharmacol Ther 1991: 51, 347-369.
8. Mohler H, Okadda T, Heitz PH, Ulrich J. Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci 1977: 77, 985-996.
9. Ritter JK, Sheen YY, Owens IS. Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. J Biol Chem 1990: 265(14), 7900-7906.
10. Ruelius HW, Tio CO, Knowles JA, McHugh SL, Schillings RT, Sisenwine SF. Diastereomeric glucuronidation of oxazepam. Isolation and stereoselective enzymic hydrolysis. Drug Met Dispos 1979: 7, 40-43.
11. Sawe J, Pacifici GM, Kager L, von Bahr C, Rane A. Glucuronidation of morphine and in human liver and interaction with oxazepam. Acta Anaesth Scand 1982: Suppl 74, 47-51.
12. Vree TB, Baars AM, Wuis EW. Direct high pressure liquid chromatographic analysis and preliminary pharmacokinetics of enantiomers of oxazepam and temazepam with their corresponding glucuronide conjugates. Pharmacol Weekbl Sci 1991: 13(2), 83-90.
13. Yang SK, Liu K, Geungerich FP. Enantioselective hydrolysis of oxazepam 3-acetate by esterases in human and rat liver microsomes and rat brain S9 fraction. Chirality 1990: 2, 150-155.